Vor Biopharma Inc. (NYSE:VOR) Receives $11.36 Average Price Target from Brokerages
Shares of Vor Biopharma Inc. (NYSE:VOR – Get Free Report) have been assigned a consensus recommendation of “Buy” from the seven research firms that are presently covering the stock, Marketbeat reports. Seven research analysts have rated the stock with a buy rating. The average 1-year target price among brokerages that have updated their coverage on […]
Shares of Vor Biopharma Inc. (NYSE:VOR – Get Free Report) have been assigned a consensus recommendation of “Buy” from the seven research firms that are presently covering the stock, Marketbeat reports. Seven research analysts have rated the stock with a buy rating. The average 1-year target price among brokerages that have updated their coverage on […]
